Your browser doesn't support javascript.
loading
Clinical applicability of Linac-integrated CBCT based NIPAM 3D dosimetry: a dual-institutional investigation.
Kunkyab, Tenzin; Lakrad, Kawtar; Jirasek, Andrew; Oldham, Mark; Quinn, Benjamin; Hyde, Derek; Adamson, Justus.
Afiliação
  • Kunkyab T; Department of Physics, University of British Columbia-Okanagan Campus, Kelowna, British Columbia, Canada.
  • Lakrad K; BC Cancer Center, Kelowna, British Columbia.
  • Jirasek A; Department of Physics, Hassan II University, Casablanca, Morocco.
  • Oldham M; Duke University Medical Center, Durham, NC.
  • Quinn B; Department of Physics, University of British Columbia-Okanagan Campus, Kelowna, British Columbia, Canada.
  • Hyde D; Duke University Medical Center, Durham, NC.
  • Adamson J; Modus Medical Devices Inc./IBA Dosimetry, London, Ontario, Canada.
Phys Med Biol ; 69(15)2024 Jul 16.
Article em En | MEDLINE | ID: mdl-38959910
ABSTRACT
Objective.To develop and benchmark a novel 3D dose verification technique consisting of polymer gel dosimetry (PGD) with cone-beam-CT (CBCT) readout through a two-institution study. The technique has potential for wide and robust applicability through reliance on CBCT readout.Approach. Three treatment plans (3-field, TG119-C-shape spine, 4-target SRS) were created by two independent institutions (Institutions A and B). A Varian Truebeam linear accelerator was used to deliver the plans to NIPAM polymer gel dosimeters produced at both institutions using an identical approach. For readout, a slow CBCT scan mode was used to acquire pre- and post-irradiation images of the gel (1 mm slice thickness). Independent gel analysis tools were used to process the PGD images (A VistaAce software, B in-house MATLAB code). Comparing planned and measured doses, the analysis involved a combination of 1D line profiles, 2D contour plots, and 3D global gamma maps (criteria ranging between 2%1 mm and 5%2 mm, with a 10% dose threshold).Main results. For all gamma criteria tested, the 3D gamma pass rates were all above 90% for 3-field and 88% for the SRS plan. For the C-shape spine plan, we benchmarked our 2% 2 mm result against previously published work using film analysis (93.4%). For 2%2 mm, 99.4% (Institution A data), and 89.7% (Institution B data) were obtained based on VistaAce software analysis, 83.7% (Institution A data), and 82.9% (Institution B data) based on MATLAB.Significance. The benchmark data demonstrate that when two institutions follow the same rigorous procedures gamma passing rates up to 99%, for 2%2 mm criteria can be achieved for substantively different treatment plans. The use of different software and calibration techniques may have contributed to the variation in the 3D gamma results. By sharing the data across institutions, we observe the gamma passing rate is more consistent within each pipeline, indicating the need for standardized analysis methods.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aceleradores de Partículas / Radiometria / Planejamento da Radioterapia Assistida por Computador / Tomografia Computadorizada de Feixe Cônico Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aceleradores de Partículas / Radiometria / Planejamento da Radioterapia Assistida por Computador / Tomografia Computadorizada de Feixe Cônico Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article